	Gastroenterology > Hereditary colorectal cancer

Date of approval: 2009-12-24, Version: 1.0, Justification: Vereniging Klinische Genetica Nederland (VKGN), Type: nation-wide guideline

References

1 - Aarnio M (1999)
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-8.

2 - Acheson LS (2000)
Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. Family history-taking in community family practice: implications for genetic screening. Genet Med. 2000;2:180-5.

3 - Aerts MCM (2007)
Aerts MCM, Popma JR. Erfelijke borst- of darmkanker en verzekerbaarheid. Onderzoek in opdracht van Breed Platform Verzekerden en Werk. Universiteit van Amsterdam, 2007.

4 - Aktan-Collan K (2000)
Aktan-Collan K, Mecklin JP, Järvinen H, Nystrom-Lahti M, Peltomäki P, Soderling I et al. Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 2000; 89: 44-50.

5 - American Gastroenterological Association (2001)
American Gastroenterological Association. Medical position statement: Hereditary colorectal cancer and genetic testing. Gastroenterology 2001:121:195-7.

6 - Anwar S (2000)
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB. Hereditary non-polyposis colorectal cancer: an updated review. Eur J Surg Oncol. 2000;26:635-45.

7 - Aoun E (2005)
Aoun E, bdul-Baki H, Azar C, Mourad F, Barada K, Berro Z et al. A randomized single-blind trial of split-dose PEG-electrolyte solution without dietary restriction compared with whole dose PEG-electrolyte solution with dietary restriction for colonoscopy preparation. Gastrointest Endosc 2005;62:213-8.

8 - Apse KA (2004)
Apse KA, Biesecker BB, Giardiello FM, Fuller BP, Bernhardt BA. Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genet Med 2004;6:510-6.

9 - Aretz S (2006)
Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C et al. MUTYH associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 2006;119:807-14.

10 - Arrigoni A (2005)
Arrigoni A, Sprujevnik T, Alvisi V, Rossi A, Ricci G, Pennazio M et al. Clinical identification and long-term surveillance of 22 hereditary non-polyposis colon cancer Italian families. Eur J Gastroenterol Hepatol 2005;17:213-9.

11 - Aronchick CA (2000)
Aronchick CA, Lipshutz WH, Wright SH, Dufrayne F, Bergman G. A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. Gastrointest Endosc 2000;52:346-52.

12 - Arvanitis ML (1990)
Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639-42.

13 - Arver B (2004)
Arver B, Haegermark A, Platten U, Lindblom A, Brandberg Y. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer 2004;3:109-16.

14 - ASCO (2003)
(ASCO) American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility. J Clin Oncol 2003:21; 2397-2406.

15 - Attanoos R (1995)
Attanoos R, Billings PJ, Hughes LE, Williams GT. Ileostomy polyps, adenomas, and adenocarcinomas. Gut 1995;37:840-4.

16 - Aziz O (2006)
Aziz O, Athanasiou T, Fazio VW, Nicholls RJ, Darzi AW, Church J et al. Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2006;93:407-17.

17 - Azizi L (2005)
Azizi L, Balu M, Belkacem A, Lewin M, Tubiana JM, Arrive L. MRI features of mesenteric desmoid tumors in familial adenomatous polyposis. Am J Roentgenol. 2005;184:1128-35.

18 - Baglietto L (2006)
Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006;59:114-24.

19 - Bandipalliam P (2005)
Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005;4: 323-33.

20 - Barclay RL (2004)
Barclay RL. Safety, efficacy, and patient tolerance of a three-dose regimen of orally administered aqueous sodium phosphate for colonic cleansing before colonoscopy. Gastrointest Endosc 2004;60:527-33.

21 - Batra S (2002)
Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol. 2002;97:729-33.

22 - Begg CB (2002)
Begg CB. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 2002;94:1221-6.

23 - Berkelhammer C (2002)
Berkelhammer C, Ekambaram A, Silva RG. Low-volume oral colonoscopy bowel preparation: sodium phosphate and magnesium citrate. Gastrointest Endosc 2002;56:89-94.

24 - Bernstein L (2006)
Bernstein L. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations. Basic Clin Pharmacol Toxicol. 2006;98:288-96.

25 - Bertario L (2000)
Bertario L, Russo A, Radice P, Varesco L, Eboli M, Spinelli P et al. Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary colorectal tumors registry. Ann Surg 2000;231:538-43.

26 - Bertario L (2001)
Bertario L, Russo A, Sala P,Eboli M, Giarola M, D'amico F et al. Genotype and phenotype factors as determinants of desmoid tumours in patients with familial adenomatous polyposis. Int J Cancer 2001;95:102-7.

27 - Biesecker BB (1997)
Biesecker BB. Psychological issues in cancer genetics. Semin Oncol Nurs 1997;13:129-34.

28 - Bijlsma EK (2005)
Bijlsma EK, Oosterwijk JC, Leschot NJ. Leerboek Medische Genetica. red. zevende druk, Elsevier gezondheidszorg, Maarssen, 2005.

29 - Björk J (2001)
Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlstrom J et al. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001;121:1127-35.

30 - Bleiker EM (2001)
Bleiker EM, Grosfeld FJ, Hahn DE, Honing C. Psychosocial care in family cancer clinics in the Netherlands: a brief report. Patient Educ Couns 2001;43:205-9.

31 - Bleiker EMA (2003)
Bleiker EMA, Hahn DE, Aaronson NK. Psychosocial issues in cancer genetics. Acta Oncol 2003;42:276-86.

32 - Bleiker EMA (2005)
Bleiker EMA, Menko FH, Taal BG, Kluijt I Wever LD, Gerritsma MA et al. Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology 2005;128:280-7.

33 - Boland CR (2005)
Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 2005;4:211-8.

34 - Bonelli L (1988)
Bonelli L, Martines H, Conio M, Bruzzi P, Aste H. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer 1988;41:513-7.

35 - Boutron MC (1995)
Boutron MC, Faivre J, Quipourt V, Senesse P, Michiels C. Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut 1995;37:830-4.

36 - Bradshaw N (2003)
Bradshaw N, Holloway S, Penman I, Dunlop MG, Porteous ME. Colonoscopy surveillance of individuals at risk of familial colorectal cancer. Gut 2003;52:1748-51.

37 - Bright-Thomas RM (2002)
Bright-Thomas RM, Agrawal A, Hargest R. Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Br J Surg 2002;89:1563-9.

38 - Brooker JC (2002)
Brooker JC, Saunders BP, Shah SG, Thapar CJ, Thomas HJ, Atikin WS et al. Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc 2002;56:333-8.

39 - Brosens LAA (2005)
Brosens LAA, Keller JJ, Offerhaus GJA, Goggins M, Giardiello FM. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 2005;54:1034-43.

40 - de Bruin JH (2005)
de Bruin JH, Kievit W, Ligtenberg MJ, Nagengast FM, Adang EM, Ruers TJ et al. Meer opsporing van erfelijke darmkanker met onderzoek op microsatellietinstabiliteit bij door de patholoog geselecteerde patiënten met een colon-rectumcarcinoom. Ned Tijdschr Geneeskd. 2005;149:1792-8.

41 - Bülow S (1987)
Bülow S. Familial polyposis coli. Dan Med Bull 1987;34:1-15.

42 - Bülow S (1995)
Bülow S, Bülow C, Nielsen TF, Karlsen L, Moesgaard F. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register. Scand J Gastroenterol 1995;30:989-93.

43 - Bülow S (2003)
Bülow S. Results of national registration of familial adenomatous polyposis. Gut 2003;52:742-6.

44 - Bülow S (2004)
Bülow S, Bjork J, Christensen IJ, Fausa O, Järvinen H, Moesgaard F et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53:381-6.

45 - Burke W (1997)
Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997;277:915-9.

46 - Burke W (2006)
Burke W, Press N. Ethical obligations and counseling challenges in cancer genetics. J Natl Compr Canc Netw 2006;4:185-91.

47 - Burke W (2006)
Burke W. Press N. Genetics as a tool to improve cancer outcomes: ethics and policy. Nature Rev Cancer 2006;6:476-82.

48 - Burt RW (2000)
Burt RW. Colon cancer screening. Gastroenterology 2000 Sep;119:837-53.

49 - Burt RW (2004)
Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 2004;127:444-51.

50 - Butterworth AS (2006)
Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006;42:216-27.

51 - Bussey HJR (1975)
Bussey HJR. Familial polyposis coli. Family studies, Histopathology, Differential diagnosis, and Results of Treatment. Baltimore: Johns Hopkins University Press; 1975.

52 - Buttin BM (2004)
Buttin BM, Powell MA, Mutch DG, Babb SA, Huttner PC, Edmonston TB et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 2004;74:1262-9.

53 - Carayol J (2002)
Carayol J, Khlat M, Maccario J, Bonaiti-Pellie C. Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. J Med Genet 2002;39:335-9.

54 - Carlsson AH (2004)
Carlsson AH, Bjorvatn C, Engebretsen LF, Berglund G, Natvig GK. Psychosocial factors associated with quality of life among individuals attending genetic counseling for hereditary cancer. J Genet Couns 2004;13:425-45.

55 - Carroll JC (1999)
Carroll JC, Heisey RE, Warner E, Goel V, MCCready DR. Hereditary breast cancer; psyhocosial issues and the physicians' role. Can Fam Phys 1999;45:126-32.

56 - De Castro SMM (2006)
De Castro SMM, Smeenk HG, Rutten JP, van Goor H, van Eijck CH, Busch ORC et al. Pancreas preserving total duodenectomy for patients with familial adenomatous polyposis of the duodenum: a comparison with standard pancreaticoduodenectomy. Abstract NVGE voorjaarsvergadering 2006

57 - Cederquist K (2005)
Cederquist K, Emanuelsson M, Wiklund F, Golovleva I, Palmqvist R, Grönberg H. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome. Clin Genet 2005;68:533-41.

58 - De la Chapelle A (2004)
De la Chapelle A. Genetic predisposition to colorectal cancer. Nature Rev. Cancer 2004; 4:769-79.

59 - Chen LM (2007)
Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB. Gynecologic cancer prevention in Lynch syndrome/HNPCC families. Obstet Gynecol 2007;110:18-25.

60 - Chow E (2004)
Chow E, Thirlwell C, MaCrae F, Lipton L. Colorectal cancer and inherited mutations in base-excision repair. Lancet Oncol 2004;5:600-6.

61 - Church J (2001)
Church J, Burke C, McGannon E, Pastean O, Clark B. Predicting polyposis severity proctoscopy: How reliable is it? Dis Colon Rectum 2001;44:1249-54.

62 - Church J (2003)
Church J, Burke C, McGannon E, Pastean O, Clark B. Risk of rectal cancer after colectomy and ileorectal anastomosis for familial adenomatous polyposis : A function of available surgical options. Dis Colon Rectum 2003;46:1175-81.

63 - Church J (2003)
Church J, Simmang C. Standards task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for treatment of patients with predominantly colorectal cancer (Familial Adenomatous Polyposis and Hereditary Nonpolyposis Colorectal Cancer). Dis Colon Rectum 2003;46:1001-12.

64 - Church J (2006)
Church J. In which patients do I perform IRA, and why? Fam. Cancer 2006;5:237-40.

65 - Cibula DA (2003)
Cibula DA, Morrow CB. Determining local colorectal cancer screening utilization patterns. J Public Health Manag Pract 2003;9:315-21.

66 - Claes E (2005)
Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Philippe K, Teipar S et al. Predictive testing for hereditary non-polyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress and health-related behaviour one year post-test. Genet Test 2005;9:54-65.

67 - Clark SK (1996)
Clark SK, Phillips RKS. Desmoids in familial adenomatous polyposis. Br J Surg 1996;83:1494-504.

68 - Clark SK (1998)
Clark SK, Smith TG, Katz DE, Reznek RH, Phillips RK. Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br J Surg 1998;85:970-3.

69 - Clark SK (1999)
Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999;86:1185-9.

70 - Clark TW (2003)
Clark TW. Percutaneous chemical ablation of desmoid tumors. J Vasc Interv Radiol 2003;14:629-34.

71 - Clarke A (1998)
Clarke A. The Genetic Testing of Children. Oxford: BIOS Scientific Publishers Ltd, 1998.

72 - Cobben JM (2002)
Cobben JM, Bröcker-Vriends AHJT, Leschot NJ. Prenatale diagnostiek naar erfelijke aanleg voor mamma/ ovariumcarcinoom - een standpuntbepaling. Ned Tijdschr Geneeskd 2002;146:1461-5.

73 - Codori AM (2003)
Codori AM, Zawacki KL, Petersen GM, Miglioretti DL, Bacon JA, Trimbath JD et al. Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A 2003;116:117-28.

74 - De Cosse JJ (1992)
De Cosse JJ, Bülow S, Neale K, Järvinen HK, Alm T, Hultcrantz R et al. Rectal cancer risk in patients treated for familial adenomatous polyposis. Br J Surg 1992;79:1372-75.

75 - Couture J (2000)
Couture J, Mitri A, Lagace R, Smits R, Berk T, Bouchard HL et al. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumour. Clin Genet 2000; 57:205-12.

76 - Croyle RT (1999)
Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 1999;25:59-66.

77 - Cruz -Correa M (2002)
Cruz-Correa M, Hylind LM, Romans K, et al. Long term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 2002;122: 641-5.

78 - Cruz-Correa M (2003)
Cruz-Correa M, Giardiello FM. Familial adenomatous polyposis. Gastrointest Endosc 2003;58:885-94.

79 - Cummings S (2000)
Cummings S. The genetic testing process: how much counseling is needed? J Clin Oncol.2000;18(21Suppl):60s-64s.

80 - Cunningham JM (2001)
Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet. 2001;69:780-90.

81 - Van Dalen R (2003)
Van Dalen R, Church J, McGannon E, Fay S, Burke C, Clark B. Patterns of surgery in patients belonging to Amsterdam-positive families. Dis Colon Rectum 2003;46:617-20.

82 - Daly MB (2005)
Daly MB, Stearman B, Masny A, Sein E, Mazzoni S. How to establish a high-risk cancer genetics clinic: limitations and successes. Curr Oncol Rep 2005;7:469-74.

83 - Davey A (2005)
Davey A, Rostant K, Harrop K, Goldblatt J, O'Leary P. Evaluating genetic counseling: client expectations, psychological adjustment and satisfaction with service. J Genet Couns 2005;14:197-206.

84 - Dekker E (2006)
Dekker E, Dees J, Mathus-Vliegen L, Poley JW, Offerhaus J, Bartelsman J et al. High-resolution endoscopy and the additional values of chromo-endoscopy in the evaluation of duodenal polyposis in FAP-patients. Abstract NVGE voorjaarsvergadering 2006.

85 - Deng G (2004)
Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10:191-5.

86 - DevCan (2005)
DevCan: Probability of Developing or Dying of Cancer Software, Version 6.1.1; Statistical Research and Applications Branch, National Cancer Institute, 2005. http://srab.cancer.gov/devcan.

87 - Domingo E (2004)
Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet. 2004;41:664-8.

88 - Domingo E (2005)
Domingo E, Niessen RC, Oliveira C, Alhopuro P, Moutinho C, Espin E et al. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene 2005 2;24:3995-8.

89 - Dørum A (1999)
Dørum A, Heimdal K, Lovslett K, Kristensen G, Hansen LJ, Sandvei R et al. Prospectively detected cancer in familial breast/ovarian cancer screening. Acta Obstet Gynecol Scand 1999;78:906-11.

90 - Dove-Edwin I (2002)
Dove-Edwin I, Boks D, Goff S, Kenter GG, Carpenter R, Vasen HF et al. The outcome of endometrial cancer surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma. Cancer 2002;94:1708-12.

91 - Dove-Edwin I (2005)
Dove-Edwin I, Sasieni P, Adams J, Thomas HJ. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 2005;331:1047.

92 - Dove-Edwin I (2006)
Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology 2006;130:1995-2000.

93 - Dunlop MG (1997)
Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10.

94 - Durno C (2007)
Durno C, Monga N, Bapat B, Berk T, Cohen Z, Gallinger S. Does early colectomy increase desmoid risk in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2007;5:1190-4.

95 - Van Duijvendijk P (1999)
Van Duijvendijk P, Vasen HF, Bertario L, Bülow S, Kuijpers JH, Schouten WR et al. Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis. J Gastrointest Surg 1999;3:325-30.

96 - Van Duijvendijk P (1999)
Van Duijvendijk P, Slors JF, Taat CW, Oosterveld P, Vasen HF. Functional outcome after colectomy and ileorectal anastomosis compared to proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis. Ann Surg 1999;230:648-54.

97 - Van Duijvendijk P (2000)
Van Duijvendijk P, Slors JF, Taat CW, Oosterveld P, Sprangers MA, Obertop H et al. Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2000;87:590-6.

98 - El Sayed AM (2003)
El Sayed AM, Kanafani ZA, Mourad FH, Soweid AM, Barada KA, Adorian CS, et al. A randomized single-blind trial of whole versus split-dose polyethylene glycol-electrolyte solution for colonoscopy preparation. Gastrointest Endosc 2003 ;58:36-40.

99 - Emery J (1999)
Emery J, Watson E, Rose P, Andermann A. A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract 1999;16:426-45. Review.

100 - Emery J (2001)
Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. Lancet 2001;358:56-63.

101 - Esplen MJ (2003)
Esplen MJ, Urquhart C, Butler K, Gallinger S, Aronson M, Wong J. The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. J Psychosom Res 2003;55:427-35.

102 - van Everdingen JJE (2004)
van Everdingen JJE, Burgers JS, Assendelft WJJ et al. red. Evidence-based Richtlijnontwikkeling. Een Leidraad voor de Praktijk. Bohn, Stafleu, Van Loghum, Houten, 2004.

103 - Evidence-based Richtlijnonwikkeling (2005)
Evidence-based Richtlijnontwikkeling. Handleiding voor werkgroepleden, Kwaliteitsinstituut voor de Gezondheidszorg CBO, april 2005.

104 - Edwards AG (2006)
Edwards AG, Evans R, Dundon J, Haigh S, Hood K, Elwyn GJ. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev 2006;4:CD001865.

105 - Fallowfield L (2001)
Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84:1011-5.

106 - Fass R (1993)
Fass R, Do S, Hixson LJ. Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus. Am J Gastroenterol 1993;88:929-32.

107 - Finch A (2006)
Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B et al. Hereditary Ovarian Cancer Clinical Study Group. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006;296:185-92.

108 - Fiorentino F (2006)
Fiorentino F, Biricik A, Nuccitelli A, De Palma R, Kahraman S, Lacobelli M et al. Strategies and clinical outcome of 250 cycles of Preimplantation Genetic Diagnosis for single gene disorders. Hum Reprod 2006;21:670-84.

109 - Fornasarig M (2006)
Fornasarig M, Minisini AM, Viel A, Quaia M, Canzonieri V, Veronesi A. Twelve years of endoscopic surveillance in a family carrying biallelic Y165C MYH defect: report of a case. Dis Colon Rectum 2006;49:1-4.

110 - Friedman LC (1999)
Friedman LC, Webb JA, Richards CS, Plon SE. Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Prev Med 1999;29:119-25.

111 - Frommer D (1997)
Frommer D. Cleansing ability and tolerance of three bowel preparations for colonoscopy. Dis Colon Rectum 1997;40:100-4.

112 - Fry A (1999)
Fry A, Campbell H, Gudmunsdottir H, Rush R, Porteous M, Gorman D et al. GPs' views on their role in cancer genetics services and current practice. Fam Pract. 1999;16:468-74.

113 - Fuchs CS (1994)
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331:1669-74.

114 - Gaarenstroom KN (2006)
Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ et al. Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int J Gynecol Cancer 2006;16 Suppl 1:54-9.

115 - Galiatsatos P (2006)
Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101:385-98.

116 - Gallagher MC (2004)
Gallagher MC, Shankar A, Groves CJ, Russel RC, Phillips RK. Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous duodenal polyposis. Br J Surg 2004; 91:1157-64.

117 - Gallagher MC (2006)
Gallagher MC, Phillips RKS, Bulow S. Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer 2006;5:263-73.

118 - Geirdal AO (2005)
Geirdal AO, Reichelt JG, Dahl AA, Heimdal K, Maehle L, Stormorken A et al. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations. Fam Cancer 2005;4;121-6.

119 - McGettigan P (2006)
McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase. JAMA 2006;296:1633-44.

120 - Giardiello FM (1997)
Giardiello FM, Brensingen JP, Petersen GM, Luce MC, Hylind LM, Bacon JA et al. The use and interpretation of commercial APC genetic testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-7.

121 - Giardiello FM (2001)
Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:198-213.

122 - Giardiello FM (2004)
Giardiello FM, Casero RA Jr, Hamilton SR, Hylind HMN, Trimbath JD, Geiman DE et al. Prostanoids, ornithine decarboxylase and polyamines in primary chemoprevention of familial adenomatous polyposis. Gastroenterology 2004;49:1259-61.

123 - Gigerenzer G (2003)
Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ 2003; 327:741-4.

124 - Gille JJP (2002)
Gille JJP, Hogervorst FBL, Pals G, Wijnen JT, Van Schooten RJ, Dommering CJ et al. Genomic deletions of MSH2 and Mlh1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002;87:892-7.

125 - Gismondi V (2004)
Gismondi V, Meta M, Bonelli O, Radice P, Sala P, Bertario L et al. Prevalence of the Y165C, G382D, and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 2004;109:680-4.

126 - Godard B (2006)
Godard B, Hurlimann T, Letendre M, Egalite N, INHERIT BRCAs. Guidelines for disclosing genetic information to family members: from development to use. Fam Cancer 2006; 5: 103-16.

127 - Graham DJ (2005)
Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005;365:475-81.

128 - Grimes DA (1999)
Grimes DA, Snively GR. Patients' understanding of medical riks: implication for genetic counselling. Obstet. Gynaecol. 1999;93:910-4.

129 - Gritz ER (2005)
Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:1902-10.

130 - Grover S (2004)
Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2004;2:813-9.

131 - Groves CJ (2002)
Groves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50:636-41.

132 - Guldenschuh I (2001)
Guldenschuh I, Hurlimann R, Muller A, Ammann R, Mullhaupt B, Dobbie Z et al. Relationship between APC genotype, polyp distribution and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Dis Colon Rectum 2001;44:1090-7.

133 - Gurbuz AK (1994)
Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-81.

134 - Haan M. de (1992)
Haan M de, Lisdonk E van de, Voorn TH. De Kern van de Huisartsgeneeskunde. Bunge Utrecht 1992.

135 - Habr-Gama A (1999)
Habr-Gama A, Bringel RW, Nahas SC, Araujo SE, Souza Junior AH, Calache JE et al. Bowel preparation for colonoscopy: comparison of mannitol and sodium phosphate. Results of a prospective randomized study. Rev Hosp Clin Fac Med Sao Paulo 1999;54:187-92.

136 - Hadley DW (2003)
Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003;163:573-82.

137 - Hadley DW (2004)
Hadley DW, Jenkins JF, Dimond E, De Carvalho M, Kirsch I, Palmer CG. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2004;22;39-44.

138 - Halbert CH (2004)
Halbert CH, Lynch H, Lynch J, Main D, Kucharski S, Rustgi AK et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 2004;164:1881-7.

139 - Hampel H (2005)
Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851-60.

140 - Hampel H (2005)
Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin J-P et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005;129:415-21.

141 - Han J (2006)
Han J, Kim MH. Technical review: Endoscopic papillectomy for adenomas of the major duodenal papilla. Gastrointest Endosc 2006;633:292-301.

142 - Harris MA (1997)
Harris MA, Byles JE. A survey of screening compliance among first degree relatives of people with colon cancer in new south wales. J Med Screen 1997;4:29-34.

143 - Harris M (2005)
Harris M, Winship I, Spriggs M. Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol 2005;6:301-10.

144 - Heinimann K (1998)
Heinimann K, Mullhaupt B, Weber W. Phenotypic differences in familial adenomatous polyposis based on APC germline mutation status. Gut 1998 43:675-9.

145 - Heiskanen I (1999)
Heiskanen I, Kellokumpu I, Järvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999;31:412-16.

146 - Hendriks YM (2004)
Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004;27:17-25.

147 - Hendriks YMC (2006)
Hendriks YMC, Jagmohan-Changur S, Van der Klift HM, Moreau H, Van Puijenbroek M, Tops C et al. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastroenterology 2006;130:312-22.

148 - Hernegger GS (2002)
Hernegger GS, Moore HG, Guillem JG. Attenuated familial adenomatous polyposis. An evolving and poorly understood entity. Dis Colon Rectum 2002;45:27-36.

149 - Higuchi (2003)
Higuchi T, Iwama T, Yoshinaga K, Toyooka M, Taketo MM, Sugihara K. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 2003;9:4756-60.

150 - Hirota WK (2006)
Hirota WK, Zuckerman MJ, Adler DG. ASGE Guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006;63:570-80.

151 - Holt WS Jr (1991)
Holt WS Jr. Factors affecting compliance with screening sigmoidoscopy. J Fam Pract. 1991;32:585-9.

152 - Holloway S (2005)
Holloway S, Porteous M, Cetnarskyj R, Rush R, Appleton S, Gorman D et al. Referrals of patients to colorectal cancer genetics services in south-east Scotland. Fam Cancer 2005;4:151-61.

153 - Hookey LC (2004)
Hookey LC, Depew WT, Vanner SJ. A prospective randomized trial comparing low-dose oral sodium phosphate plus stimulant laxatives with large volume polyethylene glycol solution for colon cleansing. Am J Gastroenterol 2004;99:2217-22.

154 - Houlston RS (1990)
Houlston RS, Murday V, Harocopos C, Williams CB, Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ 1990;301:366-8.

155 - Hsu CW (1998)
Hsu CW, Imperiale TF. Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation. Gastrointest Endosc 1998;48:276-82.

156 - Stracham T (2004)
Stracham T, Read AP, Human Molecular Genetics. red. Garland Publishing, London, New York, 2004

157 - Huppertz-Hauss G (2005)
Huppertz-Hauss G, Bretthauer M, Sauar J, Paulsen J, Kjellevold O, Majak B, et al. Polyethylene glycol versus sodium phosphate in bowel cleansing for colonoscopy: a randomized trial. Endoscopy 2005;37:537-41.

158 - Hwang KL (2005)
Hwang KL, Chen WT, Hsiao KH, Chen HC, Huang TM, Chiu CM, et al. Prospective randomized comparison of oral sodium phosphate and polyethylene glycol lavage for colonoscopy preparation. World J Gastroenterol 2005;11:7486-93.

159 - Iida M (1988)
Iida M, Yao T, Itoh H, Watanabe H, Matsui T, Iwashita A et al. Natural history of gastric adenomas in patients with familial adenomatous coli/ Gardner´s syndrome. Cancer 1988;61:605-11.

160 - Jablonska M (1995)
Jablonska M, Reznikova L, Kotrlik J, Svitavsky M, Mikova M, Tabach J. Clinical implications of recognition of the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectal cancer. Sb Lek 1995;96:275-82.

161 - James AS (2002)
James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev 2002;11:529-34.

162 - Janinis J (2003)
Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS. The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 2003;14:181-90.

163 - Järvinen HJ (1995)
Järvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.

164 - Järvinen HJ (2000)
Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000:118:829-34.

165 - Jass JR et al (1992)
Jass JR et al. Screening for hereditary non-polyposis colorectal cancer in New Zealand. Eur J Gastroenterol Hepatol 1992;4:523-27.

166 - Johns LE (2001)
Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992-3003.

167 - de Jong AE (2004)
de Jong AE, Morreau H, Van Puijenbroek M, Eilers PH, Wijnen J, Nagengast FM et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 2004;126:42-8.

168 - de Jong AE (2006)
de Jong AE, Hendriks YMC, Kleibeuker JH, De Boer SY, Cats A, Griffioen G et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006;130:665-71.

169 - de Jong AE (2006)
de Jong AE, Vasen HF. The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med 2006;64:367-70.

170 - Julian-Reynier C (2003)
Julian-Reynier C, Welkenhuysen M, Hagoel L, Decruyenaere M, Hopwood P, CRISCOM Working Group. Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services. Eur J Hum Genet. 2003;11:725-36.

171 - Jüni P (2004)
Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021-9.

172 - Kartheuser A (2006)
Kartheuser A, Stangherlin P, Brandt D, Remue C, Sempour C. Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer 2006;5:241-60.

173 - Kastrinos F (2007)
Kastrinos F. Attutudes towards PGD in patients with FAP, Am J Gastroenterol 2007;102:1284-90.

174 - Kauff ND (2002)
Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-15.

175 - Keller M (2004)
Keller M, Sommerfeldt S, Fischer C, Knigth L, Riesbeck M, Lowe B et al. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol 2004;15:1243-9.

176 - Kerber RA (1997)
Kerber RA, Slattery ML. Comparison of self reported and database linked family history of cancer data in a case-control study. Am J Epidem 1997;146:244-8.

177 - Kerber RA (1998)
Kerber RA, Slattery ML, Potter JD, Caan BJ, Edwards SL. Risk of colon cancer associated with a family history of cancer or colorectal polyps: the diet, activity, and reproduction in colon cancer study. Int J Cancer 1998;78:157-60.

178 - Kerber RA (2005)
Kerber RA, Neklason DW, Samowitz WS, Burt RW. Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer (Lynch syndrome) in a large population database. Fam Cancer 2005;4: 239-44.

179 - Kets CM (2006)
Kets CM, van Krieken JH, Hebeda KM, Wezenberg SJ, Goossens M, Brunner HG et al. Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability. Br J Cancer 2006;95:1678-82.

180 - Kiesslich R (2001)
Kiesslich R, von Bergh M, Hahn M, Hermann G, Jung M. Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy 2001;33:1001-6.

181 - Kievit W (2004)
Kievit W, de Bruin JH, Adang EM, Ligtenberg MJ, Nagengast FM, van Krieken JH et al. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis. Clin Genet. 2004;65:308-16.

182 - Kievit W (2005)
Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH et al. Cost effectiveness of a new strategy to identify HNPCC patients. Gut 2005;54:97-102.

183 - Kiesslich R (2001)
Kiesslich R, von Bergh M, Hahn M, Hermann G, Jung M. Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy 2001;33:1001-6.

184 - Kinney AY (2000)
Kinney AY, Choi YA, De Vellis B, Kobetz E, Millikan RC, Sandler RS. Interest in genetic testing among first-degree relatives of colorectal cancer patients. Am J Prev Med 2000;18:249-52.

185 - Kinzler KW (1991)
Kinzler KW, Nilbert MC, Lu LK, Vogelstein B, Bryan TM, Levy DB et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5.

186 - Kmietowicz Z (2004)
Kmietowicz Z. UK clinic allowed to screen embryos for rare bowel cancer. BMJ 2004; 329;1061.

187 - Knoppers BM (2004)
Knoppers BM, Isasi RM. Regulatory approaches to reproductive genetic testing. Hum Reprod 2004;19;2695-701.

188 - Koehly LM (2003)
Koehly LM, Peterson WK, Watts BG, Kempf KK, Vernon SW, Gritz ER. A social network analysis of communication about hereditaray nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev 2003;12;304-13.

189 - Koinuma K (2004)
Koinuma K, Shitoh K, Miyakura Y, Furukawa T, Yamashita Y, Ota J et al. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Int J Cancer. 2004;108:237-42.

190 - Kune GA (1989)
Kune GA, Kune S, Watson LF. The role of heredity in the etiology of large bowel cancer: data from the Melbourne Colorectal Cancer Study. World J Surg 1989;13:124-9.

191 - Follow-up na poliepectomie (2002)
Kwaliteitsinstituut voor de gezondheidszorg CBO. Follow-up na poliepectomie. Utrecht: van Zuiden Communications; 2002.

192 - Vroege opsporing van dikkedarmkanker (2004)
KWF kankerbestrijding. Vroege opsporing van dikkedarmkanker. Minder sterfte door bevolkingsonderzoek. Signaleringscommissie Kanker van KWF Kankerbestrijding. 2004.

193 - Labayle D (1991)
Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis, Gastroenterology 1991;101:635-9.

194 - Laframboise S (2002)
Laframboise S, Nedelcu R, Murphy J, Cole DE, Rosen B. Use of CA-125 and ultrasound in high-risk women. Int J Gynecol Cancer 2002;12:86-91.

195 - Lanspa SJ (1994)
Lanspa SJ, Jenkins JX, Cavalieri RJ, Smyrk TC, Watson P, Lynch J et al. Surveillance in Lynch syndrome: how aggressive? Am J Gastroenterology 1994;89:1978-80.

196 - Latchford A (2006)
Latchford A, Gallagher M, Newton D et al. Therapeutic endoscopy for duodenal adenomatosis in familial adenomatous polyposis. Abstract DDW 2006.

197 - Leite JS (2005)
Leite JS, Isidro G, Martins M, Regateiro F, Albuquerque O, Amaro P et al. Is prophylactic colectomy indicated in patients with MYH-associated polyposis? Colorect Dis 2005;7:327-31.

198 - Lessick M (1998)
Lessick M, Faux S. Implications of genetic testing of children and adolescents. Holist Nurs Pract 1998;12:38-46.

199 - Lewis SF (1996)
Lewis SF, Jensen NM. Screening sigmoidoscopy. Factors associated with utilization. J Gen Intern Med 1996:11:542-4.

200 - Lim CL (1986)
Lim CL, Walker MJ, Mehta RR, Das Gupta TK. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 1986;22: 583-7.

201 - Lindor NM (2005)
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005;293:1979-85.

202 - Lindor NM (2006)
Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH et al. Recommendations for the care of individuals with an inhereted predisposition to Lynch syndrome: a systematic review. JAMA 2006 296:1507-17.

203 - Lipton L (2004)
Lipton L, Tomlinson I. The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. Clin Gastroenterol Hepatol 2004;2:633-8.

204 - Lynch HT (1993)
Lynch HT, Smyrk TC, Lanspa SJ, Jenkins JX, Cavalieri J, Lynch JF. Cancer control problems in the lynch syndromes. Dis Colon Rectum 1993;36:254-60.

205 - Lynch HT (1996)
Lynch HT, Fitzgibbons R Jr. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterology 1996;91:2598-601.

206 - Lynch HT (1996)
Lynch HT, Lemon S, Smyrk T, Franklin B, Karr B, Lynch J et al. Genetic counseling in hereditary nonpolyposis colorectal cancer: an extended family with MSH2 mutation. Am J Gastroenterol 1996;91:2489-93.

207 - Lynch HT (2003)
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003; 348:919-32.

208 - Lynch HT (2004)
Lynch HT, Riley BD, Weissman SM, Coronel SM, Kinarsky Y, Lynch JF et al. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management. Cancer 2004;100:53-64.

209 - Maartense S (2004)
Maartense S, Dunker M, Slors JF, Cuesta MA, Gouma DJ, van Deventer SJ et al. Hand-assisted laparoscopic versus open restorative proctocolectomy with ileal pouch-anal anastomosis. A randomised trial. Ann Surg 2004;240:984-92.

210 - Madalinska JB (2005)
Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890-8.

211 - Madalinska JB (2006)
Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Hollenstein J, Massuger LF et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 2006;24:3576-82.

212 - Mathus-Vliegen EM (2006)
Mathus-Vliegen EM, Kemble UM. A prospective randomized blinded comparison of sodium phosphate and polyethylene glycol-electrolyte solution for safe bowel cleansing. Aliment Pharmacol Ther 2006;23:543-52.

213 - Matloff ET (2000)
Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 2000;18:2484-92.

214 - McConkie-Rosell A (2004)
McConkie-Rosell A, Spiridigliozzi GA. 'Family matters': a conceptual framework for genetic testing in children. J Genet Couns 2004;13:9-29.

215 - McGivern A (2004)
McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD et al. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 2004;3:101-7.

216 - Mecklin JP (1993)
Mecklin JP, Järvinen H. Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 1993;36:927-9.

217 - Meeuwissen PA (2005)
Meeuwissen PA, Seynaeve C, Brekelmans CT, Meijers-Heijboer HJ. Klijn JG, Burger CW. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer. Gynecol Oncol 2005;97:476-82.

218 - Meiser B (2005)
Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-oncology 2005;14:1060-74.

219 - Menko FH (1999)
Menko FH, Griffioen G, Wijnen JT, Tops CM, Fodde R, Vasen HF. Genetica van darmkanker. I. Non-polyposis en polyposisvormen van erfelijke darmkanker. Ned Tijdschr Geneeskd. 1999;143:1201-6.

220 - Menko FH (2007)
Menko FH, Ligtenberg MJ, Brouwer T, Hahn D, Ausems M. DNA diagnostiek naar erfelijke aanleg voor tumoren. Een overzicht met aanbevelingen voor de praktijk. Ned Tijdschr Geneeskd 2007; 151: 295-8.

221 - Meyer TJ (1995)
Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol 1995;14:101-8.

222 - Meyskens FL Jr (2002)
Meyskens FL Jr. Chemoprevention of FAP with sulindac. Curr Oncol Rep. 2002;4:463.

223 - Michie S (2001)
Michie S, Bobrow M, Marteau TM. Predictive genetic testing in children and adults: a study of emotional impact. J Med Genet 2001;38:519-26.

224 - Middleton SB (2003)
Middleton SB, Clark SK, Matravers P, Katz D, Reznek R, Phillips RK. Stepwise progression of familial adenomatous polyposis-associated desmoid precursor lesions demonstrated by a novel CT scoring system. Dis Colon Rectum 2003;46:481-5.

225 - Morrison PJ (2005)
Morrison PJ. Insurance, unfair discrimination, and genetic testing. Lancet 2005; 366:877-80.

226 - Moutou C (2006)
Moutou C, Gardes N, Nicod JC, Viville S. Strategies and outcomes of PGD of familial adenomatous polyposis. Mol Hum Reprod 2006;13:95-101.

227 - Mueller-Koch Y (2005)
Mueller-Koch Y, Vogelsang H, Kopp R, Lohse P, Keler G, Aust D et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005; 54, 1733-40.

228 - Müller A (2004)
Müller A, Giuffre G, Edmonston TB, Mathiak M, Roggendorf B, Heinmöller E, Brodegger T et al. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mol Diagn 2004;6:308-15.

229 - Müller W (2001)
Müller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Edmonston TB et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)-results of an international collaborative study. Fam Cancer 2001;1:87-92.

230 - Murakami Y (2004)
Murakami Y, Okamura H, Sugano K, Yoshida T, Kazuma K, Akechi T et al. Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma. Cancer 2004;101:395-403.

231 - Myrhoj T (1997)
Myrhoj T, Bisgaard ML, Bernstein I, Svendsen LB, Sondergaard JO, Bülow S. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol 1997;32:572-6.

232 - Nagengast FM (2001)
Nagengast FM, Kaandorp CJE. Herziene CBO-richtlijn 'Follow-up na poliepectomie'. Ned Tijdschr Geneeskd. 2001;145:2022-5.

233 - NCCZ (1995)
NCCZ. Advies psychosociale zorg voor chronisch zieken. Zoetermeer: Nationale Commissie Chronisch Zieken, 1995.

234 - Nederlandse Kankerregistratie
Nederlandse Kankerregistratie: www.ikcnet.nl.

235 - Neoptolemos JP (1997)
Neoptolemos JP, Russell RC, Bramhall S, Theis B. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 1997;84:1370-6.

236 - Nielsen M (2005)
Nielsen M, Franken PF, Reinards THC, Weiss MM, Wagner A, van der Klift H et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005;42:e54.

237 - Nielsen M (2006)
Nielsen M, Poley JW, Verhoef S, van Puijenbroek M, Weiss MM, Burger GT et al. Duodenal carcinoma in MUTYH-associated polyposis. J Clin Pathol. 2006;59:1212-5.

238 - Niessen RC (2006)
Niessen RC, Berends MJ, Wu Y, Sijmons RH, Hollema H, Ligtenberg MJ et al. Identification of mismatch repair gene mutations in young colorectal cancer patients and patients with multiple HNPCC-associated tumours. Gut 2006;55:1781-8.

239 - Niv Y (1994)
Niv Y, Fraser GM. Adenocarcinoma in the rectal remnant in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 1994;107:854-7.

240 - Norton ID (2001)
Norton ID, Geller A, Petersen BT, Sorbi D, Gostout CJ. Endoscopic surveillance and ablative therapy for periampullary adenomas. Am J Gastroenterol 2001;96:101-106.

241 - Norum J (2000)
Norum J, Tranebjaerg L. Health, life and disability insurance and hereditary risk for breast or colorectal cancer. Acta Oncol 2000;39:189-93.

242 - Nugent KP (1992)
Nugent KP, Phillips RK. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: A cause for concern. Br J Surg 1992;79:1204-6.

243 - Nugent KP (1993)
Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993;80:1618-9.

244 - Oei AL (2006)
Oei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA. Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer 2006;94:814-819.

245 - Offerhaus GJA (1992)
Offerhaus GJA, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980-2.

246 - Offit K (2004)
Offit K, Groeger S, Turner S, Wadsworth EA, Weiser MA. The 'duty to warn' a patient's family members about hereditary disease risks. JAMA 2004;292:1469-73.

247 - Offit K (2006)
Offit K, Kohut K, Clagett B, Wadsworth EA, Lafaro KJ, Cummings S et al. Cancer genetic testing and assisted reproduction. J Clin Oncol 2006;24:4775-82.

248 - Offringa M (2003)
Offringa M, Assendelft WJJ, Scholten RJPM, red. Bohn Stafleu Van Loghum. Inleiding in Evidence-based Medicine. Klinisch handelen gebaseerd op bewijsmateriaal., Houten, 2003.

249 - Ogino S (2006)
Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006;55:1000-6.

250 - Olivier RI (2006)
Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol 2006;100:20-6.

251 - Olivier RI (2004)
Olivier RI, van Beurden M, Lubsen MA, Rookus MA, Mooij TM, van de Vijver MJ et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. Br J Cancer 2004;90:1492-7.

252 - Oosterwijk JC (2005)
Oosterwijk JC, Ausems MGEM. Trends binnen de klinische genetica. Gebruik van erfelijkheidsonderzoek in de patiëntenzorg neemt toe. Med Contact 2005;60:1880-3.

253 - van Oostrom I (2006)
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH et al. Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Ann Oncol 2006;17:1090-5.

254 - van Oostrom I (2007)
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH et al. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing. Eur J Cancer 2007;43:71-7.

255 - Petersen GM (1996)
Petersen GM. Genetic testing and counselling in familial adenomatous polyposis. Oncology 1996;10:89-94.

256 - Peterson SK (2003)
Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK et al. How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet 2003;119C:78-86.

257 - Phillips RK (2002)
Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP et al. A randomized, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002;50:857-60.

258 - Pieterse AH (2005)
Pieterse AH , Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet A. 2005;137:27-35.

259 - Pieterse AH (2005)
Pieterse AH, Van Dulmen AM, Ausems MG, Beemer FA, Bensing JM. Communication in cancer genetic counselling: does it reflect counselees' previsit needs and preferences? Br J Cancer 2005;92:1671-8.

260 - Pieterse AH (2005)
Pieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet 2005;A 137:27-35.

261 - Piñol V (2005)
Piñol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X et al. Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005;293:1986-94.

262 - Plaschke J (2004)
Plaschke J, Engel C, Kruger S, Holinski-Feder E, Pagenstecher C, Mangold E et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 2004;22:4486-94.

263 - The Polyposis Registry (2006)
The Polyposis Registry. London, UK. Protocol for the management of patients with polyposis. A guide for medical staff, 2006.

264 - Ponz de Leon M (2004)
Ponz de Leon M, Benatti P, Di Gregorio C, Pedroni M, Losi L, Genuardi M et al. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 2004;90:882-7.

265 - Pool G (2004)
Pool G, Heuvel F, Ranchor AV, Sanderman R. Handboek Psychologische Interventies bij Chronisch-somatische Aandoeningen. Assen: Koninklijke van Gorcum, 2004.

266 - Poon R (2001)
Poon R, Smits R, Li C,Jagmohan-Changur S, Kong M, Cheon S et al. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 2001;20:451-60.

267 - Porteous M (2003)
Porteous M, Dunckley M, Appleton S, Catt S, Dunlop M, Campbell H et al. Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study. Br J Cancer 2003;89:1400-2.

268 - Quehenberger F (2005)
Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42:491-6.

269 - Ramsey SD (2003)
Ramsey SD, Wilson S, Spencer A, Geidzinska A, Newcomb P. Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives and members of the community. Results of focus group interviews. Comm. Genet. 2003;6:29-36.

270 - Rebbeck TR (2002)
Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van 't Veer L, Garber JE et al. Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-22.

271 - Remzi FH (2001)
Remzi FH, Church JM, Bast J, LAvery IC, Strong SA, Hull TL et al. Mucosectomy vs stapeled ileal pouch-anal anastomosis in patients with familial adenomatous polyposis functional outcome and neoplasia control. Dis Colon Rectum 2001;44:1590-6.

272 - Renkonen-Sinisalo L (2006)
Renkonen-Sinisalo L, Bützow R, Leminen A, Lehtovirta P, Mecklin JP, Järvinen HJ. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 2006;120:821-4.

273 - Rex DK (2000)
Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:868-77.

274 - Rich EC (2004)
Rich EC, Burke W, Heaton CJ, Haga S, Pinsky L, Short MP et al. Reconsidering the family history in primary care. J.Gen.Intern.Med. 2004;19:273-80.

275 - Richard CS (1997)
Richard CS, Berk T, Bapat BV, Haber G, Cohen Z, Gallinger S. Sulindac for periampullary polyps in FAP patients. Int J Colorectal Dis 1997;12:14-8.

276 - Richardson JL (1995)
Richardson JL, Danley K, Mondrus GT, Deapen D, Mack T. Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Prev Med 1995;24:166-70.

277 - Van Riet N (1997)
Van Riet N, Mineur MJ. Maatschappelijk werk in de (Intramurale) Gezondheidszorg. Assen: Van Gorcum, 1997.

278 - Risum S (2003)
Risum S, Bülow S. Doxorubicin treatment of an intra-abdominal desmoid tumour in a patient with familial adenomatous polyposis. Colorectal Dis 2003;5:585-6.

279 - Rijcken FEM (2002)
Rijcken FEM, Hollema H, Kleibeuker JH. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 2002;50:291-2.

280 - Rijcken FE (2003)
Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, Van der Zee AG. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2003;91:74-80.

281 - Rijcken FEM (2003)
Rijcken FEM, Van der Sluis T, Hollema H, Kleibeuker JH. Hyperplastic polyps in hereditary nonpolyposis colorectal cancer. Am J Gastroenterol 2003;98:2306-11.

282 - Robb KA (2004)
Robb KA, Miles A, Wardle J. Demographic and psychosocial factors associated with perceived risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004;13:366-72.

283 - Samowitz WS (2005)
Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837-45.

284 - Sampson JR (2003)
Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003;362:39-41.

285 - Saurin JC (2002)
Saurin JC, Ligneau B, Ponchon T, Lepretre J, Chavaillon A, Napoleon B et al. The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis. Gastrointest Endosc 2002;55:342-7.

286 - Schellevis et al (2005)
Schellevis et al. Tweede Nationale Studie, NIVEL, Utrecht 2005.

287 - Scheuer L (2002)
Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20:1260-8.

288 - Schmeler KM (2006)
Schmeler KM, Lynch HT, Chen L-M, Munsell MF, Soliman PT, Clark MB et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynchsyndrome. N Engl J Med 2006;354:261-9.

289 - Scholefield JH (1998)
Scholefield JH, Johnson AG, Shorthouse AJ. Current surgical practice in screening for colorectal cancer based on family history criteria. Br J Surg. 1998;85:1543-6.

290 - Scott RJ (2001)
Scott RJ, Mc Phillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001;68:118-27.

291 - Scott RH (2007)
Scott RH, Homfray T, Huxter NL. Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations. J Med Genet 2007;44:e83.

292 - Seinela L (2003)
Seinela L, Pehkonen E, Laasanen T, Ahvenainen J. Bowel preparation for colonoscopy in very old patients: a randomized prospective trial comparing oral sodium phosphate and polyethylene glycol electrolyte lavage solution. Scand J Gastroenterology 2003;38:216-20.

293 - Setti-Carraro P (1996)
Setti-Carraro P, Nicholls RJ. Choice of prophylactic surgery for the large bowel component of familial polyposis. Br J Surg 1996;83:885-92.

294 - Seiter K (1993)
Seiter K, Kemeny N. Successful treatment of a desmoid tumour with doxorubicin. Cancer 1993;71: 2242-4.

295 - Sermijn E (2004)
Sermijn E, Goelen G, Teugels E, Kaufman L, Bonduelle M, Neyns B et al. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet 2004;41:e23.

296 - Seow-Choen F (1996)
Seow-Choen F, Vijayan V, Keng V. Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis. Br J Surg 1996;1763-6.

297 - Shia J (2005)
Shia J, Klimstra DS, Nafa K, Offit K, Guillem JG, Markowitz AJ et al. Value of Immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 2005;29:96-104.

298 - Sieber OM (2006)
Sieber OM, Segditsas S, Knudsen AL, Zhang J, Luz J, Rowan AJ et al. Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. Gut 2006 ;55:1440-8.

299 - Sieber OM (2003)
Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK et al. Multiple colorectal adenoma, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-9.

300 - Trends, prognoses en implicaties zorgvraag (2004)
Signalerings Commissie Kanker van KWF Kankerbestrijding. Trends, Prognoses en Implicaties Zorgvraag. Oktober 2004.

301 - Signalerings Commissie Kanker (2004)
Signalerings Commissie Kanker van KWF Kankerbestrijding. De rol van voeding bij het ontstaan van kanker. KWF Kankerbestrijding 2004.

302 - Simpson JL (2005)
Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasia. J Natl Cancer Inst Monogr 2005;34:87-90.

303 - Slors JF (1995)
Slors JF, Ponson AE, Taat CW, Bosma A. Risk of residual rectal mucosa after proctocolectomy and ileal pouch-anal reconstruction with the double stapling technique. Dis Colon Rectum 1995;38:207-10.

304 - Sollner W (2001)
Sollner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001;84:179-85.

305 - Solomon SD (2005)
Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005 352;1071-80.

306 - Southey MC (2005)
Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol. 2005;23:6524-32.

307 - Spigelman AD (1989)
Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RKS. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2:783-5.

308 - Stanley AJ (2000)
Stanley AJ, Gaff CL, Aittomaki AK, Fabre LC, Macrae FA, StJohn J. Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC). Med J Aust. 2000;172:313-6.

309 - Stermer T (2004)
Stermer T, Hogdson S, Kavalier F, Watts S. Jones R. Patients' and professionals opinions of services for people at an increased risk of colorectal cancer; an exploratory qualitatieve study. Fam Cancer 2004;3;49-53.

310 - Steinbach GD (2000)
Steinbach GD, Lynch PM, Phillips RKS, Wallace MH, Hawk E, Gordon GB et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.

311 - Stephenson BM (1993)
Stephenson BM, Murday VA, Finan PJ, Quirke P, Dixon MF, Bishop DT. Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut 1993;34:96-100.

312 - Stirling D (2005)
Stirling D, Evans DG, Pichert G, Shenton A, Kirk EN, Rimmer S et al. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system. J Clin Oncol 2005;23:5588-96.

313 - St John DJ (1993)
St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.

314 - Stopfer JE (2000)
Stopfer JE. Genetic counseling and clinical cancer genetics services. Sem Surg Oncol 2000;18:347-57.

315 - Sturt NJ (2006)
Sturt NJ, Clark SK. Current ideas in desmoid tumours; Fam. Cancer 2006;5:275-85.

316 - Suthers GK (2006)
Suthers GK, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 2006;43: 665-70.

317 - Tan JJ (2006)
Tan JJ, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy - a meta-analysis. Colorectal Dis 2006;8:247-58.

318 - Tenesa A (2006)
Tenesa A, Campbell H, Barnetson R, Barnetson R, Porteous M, Dunlop M, Farrington SM. Association of MUTYH and colorectal cancer. Br J Cancer 2006;95:239-42.

319 - Thomson A (1996)
Thomson A, Naidoo P, Crotty B. Bowel preparation for colonoscopy: a randomized prospective trial comparing sodium phosphate and polyethylene glycol in a predominantly elderly population. J Gastroenterol Hepatol 1996;11:103-7.

320 - Tjandra JJ (2004)
Tjandra JJ, Tagkalidis P. Carbohydrate-electrolyte (E-Lyte) solution enhances bowel preparation with oral fleet phospho-soda. Dis Colon Rectum 2004;47:1181-6.

321 - Tourino R (2004)
Tourino R, Conde-Freire R, Cabezas-Agricola JM, Rodriguez-Aves T, Lopez-Valladares MJ, Otero-Cepeda JL et al. Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. Int Ophthalmol 2004;25:101-12.

322 - Ullah N (2002)
Ullah N, Yeh R, Ehrinpreis M. Fatal hyperphosphatemia from a phosphosoda bowel preparation. J Clin Gastroenterol 2002;34:457-8.

323 - Umar A (2004)
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-8.

324 - Umar A (2004)
Umar A, Risinger JI, Hawk ET, Barrett JC. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004;4:153-8.

325 - Vasen HF (1995)
Vasen HF, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH et al. Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer 1995;31A:1145-8.

326 - Vasen HF (1996)
Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH. Taal BG, Griffioen G et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.

327 - Vasen HFA (1996)
Vasen HFA, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348:433-5.

328 - Vasen HFA (1999)
Vasen HFA, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999;116:1453-6.

329 - Vasen HF (2001)
Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-80.

330 - Vasen HF (2005)
Vasen HF, Boland CR. Progress in genetic testing, classification, and identification of Lynch syndrome. JAMA. 2005;293:2028-30.

331 - Vasen HF (2005)
Vasen HF, Tesfay E, Boonstra H, Mourits MJ, Rutgers E, Verheyen R et al. Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer 2005;41:549-54.

332 - Venesio T (2004)
Venesio T, Molatore S, Cattaneo F, Arrigoni A, Risio M, Ranzani GN. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology 2004;126:1681-5.

333 - Vernon WS (1997)
Vernon SW, Gritz ER, Peterson SK, Amos CI, Perz CA, Baile WF et al. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer Health Psychol 1997;16:73-86.

334 - de Vos tot Nederveen Cappel (2002)
de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, Menko FH, Taal BG, Kleibeuker JH et al. Surveillance for Hereditary Nonpolyposis Colorectal Cancer. Dis Colon Rectum 2002;45:1588-94.

335 - De Vos tot Nederveen Cappel (2003)
De Vos tot Nederveen Cappel WH, Buskens E, Van-Duijvendijk P, Cats A, Menko FH, Griffioen G et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 2003;52:1752-5.

336 - Vrouenraets BC (2004)
Vrouenraets BC, van Duijvendijk P, Bemelman WA, Offerhaus GJ, Slors JF. Adenocarcinoma in the anal canal ileal pouch-anal anastomosis for familial adenomatous polyposis using a double-stapled technique: report of two cases. Dis Colon Rectum 2004;47:530-4.

337 - Wagner A (2002)
Wagner A, Tops C, Wijnen JT, Zwinderman K, van der Meer C, Kest M et al. Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. J Med Genet 2002;39:833-7.

338 - Wagner A (2005)
Wagner A, van Kessel I, Kriege MG, Tops CM, Wijnen JT, Vasen HF et al. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 2005;4:295-300.

339 - Wang L (2004)
Wang L, Baudhuin LM, Boardman LA, Steenblock KJ, Petersen GM, Halling KC et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 2004 Jul;127(1):9-16.

340 - Wallace MH (2006)
Wallace MH, Lynch PM. The current status of chemoprevention in FAP. Fam Cancer 2006;5:289-94.

341 - Watson EK (1999)
Watson EK, Shickle D, Qureshi N, Emery J, Austoker J. The 'new genetics' and primary care: GPs' views on their role and the ireducational needs. Fam Pract. 1999;16:420-5.

342 - Watson P (2001)
Watson P, Lynch HT. Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 2001;1:57-60.

343 - Weiss A (1989)
Weiss A, Lackman R. Low-dose chemotherapy of desmoid tumours. Cancer 1989;64:1192-4.

344 - Weitzel JN (1999)
Weitzel JN. Genetic cancer risk assessment Putting it all together. Cancer 1999;86(11 Suppl):2483-92.

345 - Welkenhuysen M (2001)
Welkenhuysen M, Evers-Kieboom, G. d'Ydewalle G. The language of uncertainty in genetic risk communication: framing and verbal versus numerical information. Patient Educ. Couns. 2001;43:179-87.

346 - Wennstrom J (1974)
Wennstrom J, Pierce ER, McKusick VA. Hereditary benign and malignant lesions of the large bowel. Cancer 1974;34:850-7.

347 - WHO (2000)
World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Digestive System, Hamilton, S.R. & Aaltonen, L.A., eds., IARC Press, Lyon, 2000.

348 - White WB (2007)
White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, et al. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol 2007;99:91-8.

349 - Wong N (2001)
Wong N, Lasko D, Rabelo R, Pinsky L, Gordon PH, Foulkes W. Genetic counseling and interpretation of genetic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 2001;44:271-9.

350 - Dowling DJ

Dowling DJ, St John DJ, Macrae FA, Hopper JL. Yield from colonoscopic screening in people with a strong family history of common colorectal cancer. J Gastroenterol Hepatol 2000;15:939-944.

351 - Hunt LM
Hunt LM, Rooney PS, Hardcastle JD, Armitage NC. Endoscopic screening of relatives of patients with colorectal cancer. Gut 1998; 42: 71-75

352 - Syrigos KN
Syrigos KN, Charalampopoulos A, Ho JL, Zbar A, Murday VA, Leicester RJ. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Ann Surg Oncol 2002; 9:439-443.

353 - Buchanan AH
Buchanan AH, Skinner CS, Rawl SM, Moser BK, Champion VL, Scott LL et al. Patients' interest in discussing cancer risk and risk management with primary care physicians. Patient.Educ.Couns 2005;57(1):77-87.

354 - Bleiker EMA
Bleiker EMA, Menko FH, Kluijt I, Taal BG, Gerritsma MA, Wever LDV et al. Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling. Hereditary Cancer in Clinical Practice 2007;5(2):59-66.